Grant: Canada Research Chairs
University of Toronto
$100,000.00
Neuronal RNA Biology
FY 2024-25
Summary
Genetic information from our DNA is transcribed to messenger RNA and then translated to produce proteins, the latter forming the complex machinery of our cells. The flow of information, also called gene expression, is regulated at multiple steps to produce diverse cell types, such as brain cells and muscle cells. Moreover, numerous illnesses such as cancer and neurological disorders can arise when gene expression control mechanisms go awry. Thus, a detailed understanding of how gene expression is controlled is important to combat disease and provide a basic understanding of how different cell types emerge from less specialized progenitor cells.
Dr. Calarco’s research program will develop a deeper understanding of how several specific layers of gene expression contribute to the growth, differentiation, and function of brain cells called neurons. Specifically, his group will study control mechanisms that occur at the co- and post-transcriptional steps of messenger RNA production and maturation. Using the roundworm Caenorhabditis elegans as a tractable model system, his lab will 1) identify factors controlling messenger RNA processing events in tissues and individual neuronal cell types using genetic screening approaches; 2) use high-throughput sequencing-based approaches to determine the impact of genome sequence variation on mRNA processing regulation; 3) use high-throughput genetic interaction screens to identify combinatorial interactions of RNA binding proteins that lead to defects in animal behaviour and neuronal function; and 4) Use fluorescence microscopy to create an atlas of RNA binding protein subcellular localization patterns at single neuron resolution. These objectives will provide fundamental mechanistic insight into how key steps of gene expression impact nervous system development and function. Dr. Calarco's research program will also have implications in regenerative medicine and studying disease by identifying the molecular "players" that orchestrate how cells of the brain are created and maintained, and ultimately how they can malfunction in disease.
Program
Canada Research Chairs
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
CRC-2021-00225
Name nom
Calarco, John
Department département
Cell and Systems Biology - University of Toronto
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2021
Award amount
100000
Program id
CRC
Program name en
Canada Research Chairs
Program name fr
Chaires de recherche du Canada
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
9998
Committee name en
Canada Research Chair Selection Committee
Committee name fr
Comité de sélection des Chaires de recherche du Canada
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Field of research list codes
RDF1060505
Field of research list names en
Evolution of developmental systems
Field of research list names fr
Évolution des systèmes de développement
Socioeconomic objective list codes
RDS10701
Socioeconomic objective list names en
Human health procedures and pharmaceutical treatments
Socioeconomic objective list names fr
Interventions et traitements pharmaceutiques ayant trait à la santé humaine
Application title
Neuronal RNA Biology
Keywords
RNA Biology; post-transcriptional gene regulation; Neurobiology; Genetics; Molecular Biology; Transcriptomics; Alternative Splicing; RNA processing; Neurodegenerative disorders
Application summary
Genetic information from our DNA is transcribed to messenger RNA and then translated to produce proteins, the latter forming the complex machinery of our cells. The flow of information, also called gene expression, is regulated at multiple steps to produce diverse cell types, such as brain cells and muscle cells. Moreover, numerous illnesses such as cancer and neurological disorders can arise when gene expression control mechanisms go awry. Thus, a detailed understanding of how gene expression is controlled is important to combat disease and provide a basic understanding of how different cell types emerge from less specialized progenitor cells.
Dr. Calarco’s research program will develop a deeper understanding of how several specific layers of gene expression contribute to the growth, differentiation, and function of brain cells called neurons. Specifically, his group will study control mechanisms that occur at the co- and post-transcriptional steps of messenger RNA production and maturation. Using the roundworm Caenorhabditis elegans as a tractable model system, his lab will 1) identify factors controlling messenger RNA processing events in tissues and individual neuronal cell types using genetic screening approaches; 2) use high-throughput sequencing-based approaches to determine the impact of genome sequence variation on mRNA processing regulation; 3) use high-throughput genetic interaction screens to identify combinatorial interactions of RNA binding proteins that lead to defects in animal behaviour and neuronal function; and 4) Use fluorescence microscopy to create an atlas of RNA binding protein subcellular localization patterns at single neuron resolution. These objectives will provide fundamental mechanistic insight into how key steps of gene expression impact nervous system development and function. Dr. Calarco's research program will also have implications in regenerative medicine and studying disease by identifying the molecular "players" that orchestrate how cells of the brain are created and maintained, and ultimately how they can malfunction in disease.